USFDA grants Qualified Infectious Disease Product status to two Wockhardt drugs – The Economic Times
0
Drug maker Wockhardt today said that two of its anti-infective drugs have received Qualified Infectious Disease Product (QIDP) status from the US health regulator.
Two drugs – WCK 771 and WCK 2349 – have received QIDP status, which allows fast-track review of the drug application by the US Food and Drug Administration (USFDA), Wockhardt said in a statement.
This is the first instance of an Indian pharmaceutical company receiving QIDP status, it added.
Read more – The Economic Times